New ASRM guidelines on fertility treatment and COVID-19 Coronavirus

Infertility can be very stressful and is extremely expensive costing tens of thousands of dollars. As of March 17, 2020, the American Society for Reproductive Medicine (ASRM) has issued new guidelines specifically for patients undergoing fertility treatments. 

Here is what the ASRM says:

This ASRM guidance is in response to the coronavirus (COVID-19) global pandemic. Our goal is to provide practices with recommendations that guard the health and safety of our patients and staff and recognize our social responsibility, as an organization and as a community of providers and experts, to comply with national public health recommendations. This guidance recommends the following:

  1. Suspend initiation of new treatment cycles, including ovulation induction, intrauterine inseminations (IUIs), in vitro fertilization (IVF) including retrievals and frozen embryo transfers, as well as non-urgent gamete cryopreservation.
  2. Strongly consider cancellation of all embryo transfers whether fresh or frozen.
  3. Continue to care for patients who are currently “in-cycle” or who require urgent stimulation and cryopreservation.
  4. Suspend elective surgeries and non-urgent diagnostic procedures.
  5. Minimize in-person interactions and increase the utilization of telehealth.

Note: This guidance will be revisited periodically as the pandemic evolves, but no later than March 30, 2020, with the aim of resuming usual patient care as soon and as safely as possible.

The New Model of Prenatal Care in the Age of COVID-19

Read More: